Patent no loss of MatrixView
Tuesday, 19 August, 2008
MatrixView [ASX: MVU] has been awarded a European Patent for its proprietary ABO technology.
The patent has been awarded for the company's proprietary Advanced Binary Optimisation (ABO) technology, which allows MatrixView's healthcare products to provide lossless data streams.
ABO is the backbone of MatrixView's healthcare products - such as its tele-radiology solution - where high-resolution, highly accurate data streams are required.
Its key feature is an ability to provide mathematically lossless data management – the ability to compress large amounts of data without losing any of that data, critical in medical applications.
The company has also applied for patents for ABO from the US.
Novel antibiotic activates 'suicide' mechanism in superbug
Researchers have discovered a new class of antibiotic that selectively targets Neisseria...
Modifications in the placenta linked to psychiatric disorders
Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...
ADHD may be linked with an increased risk of dementia
An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...
